Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Recursion Pharmaceuticals Inc (NASDAQ: RXRX) closed at $7.80 in the last session, up 8.18% from day before closing price of $7.21. In other words, the price has increased by $8.18 from its previous closing price. On the day, 15.56 million shares were traded. RXRX stock price reached its highest trading level at $7.83 during the session, while it also had its lowest trading level at $7.17.
Ratios:
We take a closer look at RXRX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.35 and its Current Ratio is at 4.35. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.14.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on May 22, 2023, initiated with a Equal-Weight rating and assigned the stock a target price of $8.
On March 16, 2023, Needham started tracking the stock assigning a Buy rating and target price of $17.
On September 16, 2022, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $20.KeyBanc Capital Markets initiated its Overweight rating on September 16, 2022, with a $20 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 26 ’24 when Marriott Tina bought 6,000 shares for $7.46 per share.
Secora Michael bought 15,000 shares of RXRX for $112,182 on Dec 11 ’24. On Dec 10 ’24, another insider, Secora Michael, who serves as the Officer of the company, bought 15,000 shares for $7.75 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXRX now has a Market Capitalization of 3047631616 and an Enterprise Value of 1900316288. For the stock, the TTM Price-to-Sale (P/S) ratio is 50.59 while its Price-to-Book (P/B) ratio in mrq is 4.25. Its current Enterprise Value per Revenue stands at 29.153 whereas that against EBITDA is -5.218.
Stock Price History:
Over the past 52 weeks, RXRX has reached a high of $15.74, while it has fallen to a 52-week low of $5.60. The 50-Day Moving Average of the stock is 14.03%, while the 200-Day Moving Average is calculated to be 2.18%.
Shares Statistics:
According to the various share statistics, RXRX traded on average about 10.29M shares per day over the past 3-months and 15934430 shares per day over the past 10 days. A total of 390.76M shares are outstanding, with a floating share count of 323.51M. Insiders hold about 17.21% of the company’s shares, while institutions hold 57.88% stake in the company. Shares short for RXRX as of 1734048000 were 67097533 with a Short Ratio of 6.52, compared to 1731628800 on 64573303. Therefore, it implies a Short% of Shares Outstanding of 67097533 and a Short% of Float of 18.72.
